Forget Aurora Cannabis: Buy This Pot Stock Instead!

Aurora Cannabis (TSX:ACB)(NYSE:ACB) just isn’t the hot buy it was a couple years ago.

| More on:
edit Jars of marijuana

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Aurora Cannabis (TSX:ACB)(NYSE:ACB) is coming off yet another disappointing quarterly result. The company’s shares crashed more than 29% on Wednesday after investors saw its abysmal fourth-quarter performance.

Not only was its Q4 net revenue of $72.1 million down from $75.5 million in the previous quarter, but Aurora also reported a staggering net loss from continuing operations of $1.86 billion. But after backing out impairment and other costs, its adjusted EBITDA figure came in at $34.6 million — an improvement from the $50.4 million adjusted EBITDA loss the Alberta-based company reported in Q3.

The bigger problem, however, is the company’s guidance for the first quarter of 2021. Aurora said that now that it’s divested of its non-core subsidiaries, its net revenue will now mainly be composed primarily of cannabis sales. And it’s only expecting that number to come in at no higher than $64 million for Q1. Not only is this down from the current period’s net revenue, but in Q4, Aurora notes that its net cannabis revenue was also higher at $67.5 million.

For a growth stock, Aurora’s going in the wrong direction. It’s little wonder that its shares have cratered more than 90% in the past 12 months, as investors are growing tired of the company’s underwhelming performances.

A better option for investors

If you’re fed up with Aurora and are looking for a better pot stock to buy, consider Village Farms International (TSX:VFF)(NASDAQ:VFF). Although the British Columbia-based cannabis producer is struggling, at around 50%, its losses over the past year aren’t nearly as bad as Aurora’s.

And there’s reason to be optimistic. Village Farms’ financials may get a whole lot better now that the company owns Pure Sunfarms in its entirety. On September 8, the company announced it was buying out the remaining stake that Emerald Health held in the low-cost cannabis producer. Village Farms did previously own a majority stake in Pure Sunfarms, but now it will benefit from the company’s entire success and profitability, not longer receiving just a fraction of it.

The importance of this move shouldn’t be understated by investors as Pure Sunfarms often plays a major role in bolstering Village Farms’ overall financials. Through the first six months of 2020, its share of earnings from Pure Sunfarms was just under US$4 million. Village Farms’ pre-tax income before adding in income from unconsolidated entities (including Pure Sunfarms) for the first two quarters totaled just US$492k, just above breakeven.

With a greater stake in Pure Sunfarms, it should put Village Farms in much better shape to compete on price and deliver stronger results for its shareholders. Reporting a US$119k loss in its most recent quarter, the company just fell short of the breakeven mark in Q2.  But in four of its past seven quarterly results, Village Farms was able to stay in the black.

Profitability is a much more realistic target for Village Farms, and the company’s still growing its top line as well. Sales of US$47.6 million this past quarter rose by 15% year over year.

With shares of Village Farm trading at just two times revenue, this could be one of the better cannabis investments out there on the TSX.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned. The Motley Fool owns shares of Village Farms International, Inc.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »